Related Experiment Videos
[Effects of beta-adrenergic compounds on IgE production]
1Molecular Oncology group, Royal Victoria Hospital, McGill University, Montreal, Québec, Canada.
Abstract:
We studied the effects of beta 2-adrenoceptor agonist on IgE production in vitro in human and in vitro and in vivo in mouse. We observed that salbutamol and fenoterol potentiate the IL-4-induced IgE production from peripheral blood mononuclear cells. This effect is associated by an enhanced mRN expression for IgE. Fenoterol also potentiated, but in a lesser extent, the IgE production from purified B lymphocytes stimulated by both IL-4 and CD40, suggesting that the activity of beta 2-adrenoceptor agonist is mediated through T lymphocyte or monocyte modulation. Fenoterol also inhibited the PHA-induced IFN-gamma production by T lymphocytes. Analogues of cAMP or activator of PKA also elicited an increase in IgE production. Moreover, the effect of fenoterol on IgE production was suppressed in the presence of PKA inhibitor. Salbutamol also potentiated the IL-4-induced IgE production from murine splenocytes activated by LPS. Furthermore, mice sensitized to ovalbumin elicited increased IgE responses after daily injection of salbutamol. This was accompanied by an increased in cytokines of Th2 subtypes. Our results showed that beta 2-adrenoceptor agonist, which are currently used in the treatment of asthma, potentiate the IgE production in vitro and in vivo.
Insights
Beta 2-adrenoceptor agonists, used for asthma, increase immunoglobulin E (IgE) production. This occurs both in lab settings and in living organisms, potentially impacting allergic responses.
Area of Science:
- Immunology
- Pharmacology
- Allergy Research
Background:
- Beta 2-adrenoceptor agonists are common asthma medications.
- Their effect on immunoglobulin E (IgE) production, a key allergic mediator, requires further investigation.
Purpose of the Study:
- To investigate the impact of beta 2-adrenoceptor agonists on IgE production.
- To explore the mechanisms underlying these effects in both human and murine models.
Main Methods:
- In vitro studies using human peripheral blood mononuclear cells and purified B lymphocytes.
- In vivo studies involving ovalbumin-sensitized mice.
- Analysis of IgE production, mRNA expression, cytokine profiles, and effects of signaling pathway modulators (cAMP, PKA inhibitors).
Main Results:
- Salbutamol and fenoterol potentiated Interleukin-4 (IL-4)-induced IgE production in human cells.
- This potentiation correlated with increased IgE mRNA expression.
- Fenoterol also enhanced IgE production in purified B cells and inhibited T-lymphocyte IFN-gamma production.
- In vivo, salbutamol increased IgE responses in ovalbumin-sensitized mice, associated with Th2 cytokine shifts.
- The effects were linked to cAMP-PKA signaling pathways.
Conclusions:
- Beta 2-adrenoceptor agonists can enhance IgE production through mechanisms involving T-lymphocyte or monocyte modulation.
- These findings suggest a potential link between common asthma treatments and exacerbation of allergic responses.
- Further research is warranted to understand the clinical implications for allergic patients.